Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Riboflavin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 1/20 | 0.78 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.78 |
| ▸ | MEN1 | O00255 | 7/20 | 0.92 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.92 |
| ▸ | USP2 | O75604 | 4/20 | 0.92 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.92 |
| ▸ | HAT1 | O14929 | 4/20 | 0.92 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.92 |
| ▸ | HTT | P42858 | 4/20 | 0.92 |
| ▸ | RECQL | P46063 | 3/20 | 0.92 |
| ▸ | CASP7 | P55210 | 3/20 | 0.92 |
| ▸ | MAPT | P10636 | 3/20 | 0.92 |
| ▸ | CASP1 | P29466 | 2/20 | 0.92 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.92 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.92 |
| ▸ | TST | Q16762 | 2/20 | 0.92 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.92 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.92 |
| ▸ | LMNA | P02545 | 1/20 | 0.92 |
| ▸ | HBB | P68871 | 1/20 | 0.92 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Riboflavin SCHEMBL22034360 | 1.00 | MEN1 (0.92) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL826819 | 1.00 | MEN1 (0.92) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL20528621 | 0.99 | MEN1 (0.90) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL2241200 | 0.99 | MEN1 (0.90) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL27628044 | 0.99 | MEN1 (0.90) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL20474794 | 0.99 | MEN1 (0.90) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL27796272 | 0.98 | MEN1 (0.89) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL28875504 | 0.98 | MEN1 (0.89) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL7707 | 0.96 | MEN1 (1.00) | MEN1KMT2AUSP2KDM4EHAT1 | |
| Riboflavin SCHEMBL5899262 | 0.96 | MEN1 (1.00) | MEN1KMT2AUSP2KDM4EHAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1317 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12516206-B2 | Edible ink formulations, articles of manufacture, and related methods of forming images by droplet deposition | RIPPLES LTD (IL) | 2026-01-06 | — | — | US | claimed |
| US-12503616-B2 | Apparatus, method and article of manufacture for producing an edible multi-color ink-image | Ripples Ltd. (IL) | 2025-12-23 | — | — | US | claimed |
| CN-120132189-A | Drug-loaded balloon catheter system | 杭州矩正医疗科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-116924868-B | Visible light catalytic lysine selective modification method and application | 深圳湾实验室坪山生物医药研发转化中心 | 2025-05-27 | — | — | CN | claimed |
| CN-119909239-A | Drug-carrying device for forming in-situ vascular stent and preparation method | 杭州矩正医疗科技有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119909240-A | Pharmaceutical composition, drug-loaded device and therapeutic system for forming enhanced in situ vascular stents | 杭州矩正医疗科技有限公司 | 2025-05-02 | — | — | CN | claimed |
| WO-2025037676-A1 | HYALURONIC ACID HYDROGEL HAVING SKIN WOUND HEALING EFFECT BY CONTINUOUSLY RELEASING DRUG, AND HYALURONIC ACID HYDROGEL CAPABLE OF CONTROLLING DRUG RELEASE BY MEANS OF LIGHT BY USING PHOTO-CLEAVABLE LINKER | 가천대학교 산학협력단 | 2025-02-20 | — | — | WO | claimed |
| WO-2024225436-A1 | OPHTHALMIC COMPOSITION | 株式会社メドレックス | 2024-10-31 | — | — | WO | claimed |
| CN-117813375-A | Method for selectively tolerating-selectively generating tolerogenic dendritic cells | 特兰西穆内有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117257833-A | Metal riboflavin nano material and transepithelial cornea crosslinking preparation | 复旦大学附属眼耳鼻喉科医院 | 2023-12-22 | — | — | CN | claimed |
| EP-1190706-A1 | LIPOSOMES | TERUMO KABUSHIKI KAISHA (JP) | 2002-03-27 | — | — | EP | claimed |
| EP-1177728-A1 | SUCRALOSE-CONTAINING COMPOSITION AND EATABLE PRODUCT COMPRISING THE SAME | SAN-EI GEN F.F.I., INC. (JP) | 2002-02-06 | — | — | EP | claimed |
| EP-0397362-B1 | Electrochemical detection of growth of micro-organisms | METAL BOX PLC (GB) | 1995-06-21 | — | — | EP | claimed |
| US-5300428-A | Adding electrochemically reducible, consumable indicator to nutrient solution, detecting change in electrical properties with immersed electrodes | CMB PACKAGING (UK) LIMITED (GB) | 1994-04-05 | — | — | US | claimed |
| WO-1991007167-A1 | PROTEIN KINASE ACTIVATORS AS ENHANCERS OF MELANIN PRODUCTION | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-05-30 | — | — | WO | claimed |
| WO-1991007168-A1 | RIBOFLAVIN AS A TANNING ENHANCER | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1991-05-30 | — | — | WO | claimed |
| EP-0270291-A1 | Riboflavin-linked assay procedures and materials | London Biotechnology Limited (GB) | 1988-06-08 | — | — | EP | claimed |
| EP-0019054-B1 | NUTRIENT MEDIUM AND ITS USE IN TESTING ANTIMICROBIAL AGENTS | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-05-05 | — | — | EP | claimed |
| US-4275154-A | Nutrient medium | HOFFMANN-LA ROCHE INC. (US) | 1981-06-23 | — | — | US | claimed |
| EP-0019054-A1 | Nutrient medium and its use in testing antimicrobial agents | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1980-11-26 | — | — | EP | claimed |